Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumorsJason J. Luke, Stéphane Champiat, Dejan Juric et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 34
Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancersStéphane Champiat, Aurélien Marabelle|Cell Reports Medicine|2025Cited by 5